16
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Audiological assessment in patients with mitochondrial myopathy

, , &
Pages 231-240 | Published online: 12 Oct 2009

References

  • Berenberg RA, Pellock JM, DiMauro S, et al. Lumbing or splitting? "Ophthalmoplegia-plus" or Kearns-Sayre syn-drome? Ann Neurol 1977;1:37–54.
  • Berkovic SF, Carpenter S, Evans A, et al. Myoclonus epilepsy and ragged-red fibers (M ERRE): A clinical, pathological, biochemical, magnetic resonance specto-graphic and position emission tomographic study. Brain 1989;112:1231–60.
  • Cortopassi G, Hutchin TA. Molecular and cellular hypoth-esis for aminoglycoside-induced deafness. Hear Res 1994;78:27–30.
  • DiMauro S, Bonilla E, Zeviani M, Nakagawa M, DeVivo DC. Mitochondrial myopathies. Ann Neurol 1985;17: 521–38.
  • Donovan TJ. Mitochondrial encephalomyopathy: A rare genetic cause of sensorineural hearing loss. Ann Otol Rhinol Laryngol 1995;104:786–92.
  • Elverland HEL Torbergsen T. Audiologic findings in a family with mitochondrial disease. Am J Otol 1991;12: 459–65.
  • Fadic R, Johns DR. Clinical spectrum of mitochondrial diseases. Semin Neurol 1996;16:11–20.
  • Fukuhara N, Tokiguchi S, Shirakawa K, Tsubaki T. Myoclonus epilepsy associated with ragged-red fibers (mitochondrial abnormalities): disease entity or syn-drome? Light- and electron-microscopic studies of two cases and review of literature. J Neurol Sci 1980;47:117–33.
  • Ghodsian FN, Prezant TR, Chaltraw WE, Wendt KA, Nelson RA, Amos KS, Falk RE. Mitochondrial gene mutation is a significant predisposing factor in amino-glycoside ototoxicity. Am J Otolaryngol 1997;18:173–8.
  • Goto Y, Horai S, Matsuoka T, Koga Y, Nihei K, Kobayashi M, Nonaka I. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): a correlative study of the clinical features and mitochon-drial DNA mutation. Neurology 1992;42:545–50.
  • Hu D-N, Qiu W-Q, Wu B-T, Fang L-Z, Zhou F, Gu Y-P, et al. Genetic aspects of antibiotic induced deafness: mitochondrial inheritance. J Med Genet 1991;28:79–83.
  • Jaber L, Shohat M, Bu X, Fischel-Ghodsian N, Yang H-Y, Wang S-J, Rotter JI. Sensorineural deafness inherited as a tissue specific mitochondrial disorder. J Med Genet 1992;29:86–90.
  • Johnston W, Karpati G, Carpenter S, Arnold D, Shoubridge E. Late-onset mitochondrial myopathy. Ann Neurol 1995;37:24–9.
  • Kageyama Y, Ichikawa K, Fujioka A, Tsutsumi A, Yorifuji S, Miyoshi K. An autopsy case of mitochondrial myopathy with prominent degeneration in olivo-ponto-cerebellar system. Acta Neuropathol (Berlin) 1991;83: 99–103.
  • Karpati G, Arnold D, Matthews P, Carpenter S, Andermann F, Shoubridge E. Correlative multidisciplinary approach to the study of mitochondrial encephalomyopathies. Rev Neurol (Paris) 1991;147:455–61.
  • Kearns TP, Sayre GP. Retinitis pigmentosa, extemal ophthalmoplegia, and complete heart block: Unusual syndrome with histologic study in one of two cases. Arch Ophthalmol 1958;60:280–9.
  • Larsson N-G, Clayton DA. Molecular genetic aspects of human mitochondrial disorders. Ann Rev Genet 1995; 29:151–78.
  • Lindsay JR, Hinojosa R. Histopathologic features of the inner ear associated with Keams-Sayre syndrome. Arch Otolaryngol 1976;102:747–52.
  • Linnane AW, Marzuki S, Ozawa T, Tanaka M. Mitochon-drial DNA mutations as an important contributor to age-ing and degenerative diseases. Lancet 1989;1:642–5.
  • Maassen JA, Kadowaki T. Maternally inherited diabetes and deafness: a new diabetes subtype. Diabetologia 1996;39:375–82.
  • Mckelvie PA, Morley JB, Byrne E, Marzuki S. Mitochon-drial enuphalomyopathies: a correlation between neuro-pathologic findings and defects in mitochondrial DNA. J Neurol Sci 1991;102:51–60.
  • Moraes CT. Mitochondrial diseases. Curr Opin Neurol 1996;9:369–74.
  • Morgan Hughes JA. Mitochondrial disorders. In: Engel AG, Banker BQ, Armstrong CF, eds. Myology. 2nd edn. New York: McGraw-Hill, 1994;1610–60.
  • Nishino I, Seki A, Maegaki Y, et al. A novel mutation in the mitochondrial tRNA (Thr) gene associated with a mitochondrial encephalomyopathy. Biochem Biophys Res Commun 1996;225:180–5.
  • Oshima T, Ueda N, Ikeda K, Abe K, Takasaka T. Bilateral sensorineural hearing loss associated with the point mutation in mitochondrial genome. Laryngoscope 1996;106:43–8.
  • Pavlakis SG, Phillips PC, DiMauro S, De Vivo DC, Rowland LP. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol 1984;16:481–8.
  • Petty RKH, Harding AE, Morgan-Hughes JA. The clinical features of mitochondrial myopathy. Brain 1986;109: 915–38.
  • Piccolo VM, Callieco R, Bergamaschi R, et al. Multimodal evoked potentials in progressive external ophthalmople-gia with mitochondrial myopathy. Acta Neurol Scand 1991;84:107–10.
  • Riordan-Eva P, Wood NW. Mitochondrial disorders in neuro-ophthalmology. Curr Opin Neurol 1996;9:1–4.
  • Robinson DW, Sutton GJ. Age effect in hearing - a comparative analysis of published threshold data. Audiology 1979;18:320–34.
  • Sartucci F, Rossi B, Tognoni G, Siciliano G, Guerrini V, Murri L. Evoked potentials in the evaluation of patients with mitochondrial myopathy. Eur Neurol 1993;33:428–35.
  • Schubert M, Zierz S, Dengler R. Central and peripheral nervous system conduction in mitochondrial myopathy with chronic progressive external ophthalmoplegia. Electroencephalogr Clin Neurophysiology 1994;90: 304–12.
  • Shapira Y, Harel S. The mitochondrial encephalomyopa-thies: a group of neuromuscular disorders with defects in oxidative pathways of energy production. Child Neuro-logical Society meeting. Abstract 33,1975.
  • Shoffner JIM, Lott MT, Lezza AMS, Seibel P, Ballinger SW, Wallace DC. Myoclonic epilepsy and ragged-red fiber disease (M ERRE) is associated with a mitochon-drial DNA tRNALY mutation. Cell 1990;61:931–7.
  • Smith SJM, Harding AE. EEGs and evoked potentials in mitochondrial myopathy. J Neurol 1993;240:367–72.
  • Swift AC, Singh SD. Hearing impairment and the Kearns-Sayre syndrome. J Laryngol Otol 1988;102:626–7.
  • Tamagawa Y, Kitamura K, Hagiwara H, Ishida T, Nishizawa M, Saito T, Iwamoto Y. Audiologic findings in patients with a point mutation at nucleotide 3,243 of mitochondrial DNA. Ann Otol Rhinol Laryngol 1997; 106:338–42.
  • Thalmann I, Matschinsky FM, Thalmann R. Quantitative study of selected enzymes involved in energy metabol-ism of the cochlear duct. Ann Otolaryngol 1970;79:12–29.
  • Torbergsen T, Mathiesen E, Aasly J. Epilepsy in a mitochondrial disorder. J Neurol Neurosurg Psychiatry 1991;54:1073–6.
  • Wallace DC. Mitochondrial genetics: a paradigm for aging and degenerative diseases. Science 1992;256:628–32.
  • Wallace DC. Mitochondrial DNA mutations in diseases of energy metabolism. Bioenerg Biomemb 1994;246:241–50.
  • Wallace DC, Zheng X, Lott MT, et al. Familial mitochon-drial encephalomyopathy (MERRF): genetic, patho-physiological, and biochemical characterization of a mitochondrial DNA disease. Cell 1988;55:601–10.
  • Yorifuji T, Kawai M, Momoi T, et al. Nephropathy and growth hormone deficiency in a patient wth mitochon-drial tRNALe"(uuR) mutation. J Med Genet 1996;33:621–2.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.